Trial intelligence / Profile preview

AIDA: Anakinra in New Onset Type 1 Diabetes

NCT00711503Phase 3Completed

Sponsor
Steno Diabetes Center Copenhagen
Start
Jan 2009
Primary completion
Jan 2012
Modality
Cytokines & Interferons
Countries
7
01

Overview

A Phase 3 trial of anakinra in type 1 diabetes mellitus (T1D), sponsored by Steno Diabetes Center Copenhagen. Started Jan 2009; status: completed.

02

Drugs

anakinra
03

Conditions

type 1 diabetes mellitus (T1D)

Beyond the preview

Go deeper on NCT00711503.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00711503.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call